900909:SSEShanghai Huayi Group Corporation Ltd. Class B Analysis
Data as of 2026-08-02 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Shanghai Huayi Group is trading at ¥0.506, comfortably above its 20‑day (¥0.494) and 50‑day (¥0.492) simple moving averages but still below the 200‑day SMA (¥0.522), suggesting short‑term momentum without a long‑term breakout. The 14‑day RSI sits at 62, indicating the stock is in the higher‑than‑average range but not yet overbought, while the MACD histogram is positive and the signal line is bullish, reinforcing a modest upside bias. Volume has been increasing, adding conviction to the technical picture, and the beta of roughly 0.17 points to very low market‑risk sensitivity. On the valuation side, the price‑to‑earnings ratio of 12.6 and price‑to‑book of 0.32 are well below industry norms, and the dividend yield of 3.19% with a 66% payout ratio is supported by strong operating cash flow (¥6.5 bn) and a net cash position (cash ¥16.5 bn vs debt ¥12.6 bn). However, profitability is thin—gross margin 7.5%, operating margin 2.5% and ROE only 1.9%—and revenue growth is modest at 1.6% YoY, flagging limited growth prospects. The DCF‑derived fair value of ¥11.15 versus the current price underscores a deep valuation gap, though the mismatch may reflect currency or unit differences. Overall, the stock appears undervalued from a pure valuation lens, but the low growth and thin margins temper enthusiasm.
Market Outlook
Short Term
< 1 yearKey Factors
- Price above short‑term SMAs with bullish MACD
- RSI in upper‑mid range indicating limited upside
- Increasing volume supporting current trend
Medium Term
1–3 yearsKey Factors
- Significant valuation discount (low P/E, low P/B)
- High dividend yield with sustainable payout
- Strong net cash position and low beta reducing market risk
Long Term
> 3 yearsKey Factors
- Thin margins and modest revenue growth limit upside
- Potential regulatory headwinds in the chemicals sector
- Continued dividend income offsets growth concerns
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.